Effects of heat shock protein gp96 on human dendritic cell maturation and CTL expansion

Biochemical and Biophysical Research Communications

Volumn 344, Issue 2, 2006, Pages 581-587

  Zhang, Yuxia ^a,b   Zan, Yanlu ^a,b   Shan, Ming ^a   Liu, Changmei ^a   Shi, Ming ^c   Li, Wei ^d   Zhang, Zhixin ^d   Liu, Na ^d   Wang, Fusheng ^c   Zhong, Weidong ^e   Liao, Fulian ^a   Gao, George F ^a   Tien, Po ^a  

^a INSTITUTE OF MICROBIOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c BEIJING 302 HOSPITAL   (China)

^d BEIJING RED CROSS BLOOD CENTER   (China)

^e GILEAD SCIENCES   (United States)

Author keywords

Cytotoxic T lymphocyte; Heat shock protein gp96; Hepatitis B virus; Monocyte derived dendritic cells; Peptide; Transgenic mice

Indexed keywords

EPITOPE; GLYCOPROTEIN GP 96; HEAT SHOCK PROTEIN; HEPATITIS B CORE ANTIGEN; HLA A2 ANTIGEN; PHENYLALANYLLEUCYLPROLYLSERYLASPARTYLPHENYLALANYLPHENYLALANYLPROLYLSERYL VALINE; PROTEIN SUBUNIT; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CANCER PATIENT; CELL MATURATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DONOR; DRUG EFFECT; EUKARYOTIC CELL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNOTHERAPY; IN VITRO STUDY; LIVER; LIVER CELL CARCINOMA; LYMPHOCYTE ACTIVATION; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROKARYOTIC CELL; PROTEIN FUNCTION; PROTEIN ISOLATION; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE; VACCINATION;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DENDRITIC CELLS; HEAT-SHOCK PROTEINS; HEPATITIS B; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; T-LYMPHOCYTES, CYTOTOXIC;

ANIMALIA; EUKARYOTA; HEPATITIS B VIRUS; MUS MUSCULUS; PROKARYOTA;

EID: 33646103907     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.03.171     Document Type: Article

References (33)

1. Tavakoli S., Schwerin W., Rohwer A., Hoffmann S., Weyer S., Weth R., Meisel H., Diepolder H., Geissler M., Galle P.R., Lohr H.F., and Bocher W.O. Phenotype and function of monocyte derived dendritic cells in chronic hepatitis B virus infection. J. Gen. Virol. 85 (2004) 2829-2836
2. Zheng B.J., Zhou J., Qu D., Siu K.L., Lam T.W., Lo H.Y., Lee S.S., and Wen Y.M. Selective functional deficit in dendritic cell-T cell interaction is a crucial mechanism in chronic hepatitis B virus infection. J. Viral Hepat. 11 (2004) 217-224
3. Hasebe A., Akbar S.M., Furukawa S., Horiike N., and Onji M. Impaired functional capacities of liver dendritic cells from murine hepatitis B virus (HBV) carriers: relevance to low HBV-specific immune responses. Clin. Exp. Immunol. 139 (2005) 35-42
4. Li R.B., Chen H.S., Xie Y., Fei R., Cong X., Jiang D., Wang S.X., Wei L., and Wang Y. Dendritic cells from chronic hepatitis B patients can induce HBV antigen-specific T cell responses. World J. Gastroenterol. 10 (2004) 1578-1582
5. Janetzki S., Palla D., Rosenhauer V., Lochs H., Lewis J.J., and Srivastava P.K. Immunization of cancer patients with autologous cancer-derived heat shock protein gp96 preparations: a pilot study. Int. J. Cancer 88 (2000) 232-238
6. Mazzaferro V., Coppa J., Carrabba M.G., Rivoltini L., Schiavo M., Regalia E., Mariani L., Camerini T., Marchiano A., Andreola S., Camerini R., Corsi M., Lewis J.J., Srivastava P.K., and Parmiani G. Vaccination with autologous tumor-derived heat-shock protein gp96 after liver resection for metastatic colorectal cancer. Clin. Cancer Res. 9 (2003) 3235-3245
7. Srivastava P. Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses. Annu. Rev. Immunol. 20 (2002) 395-425
8. Srivastava P. Roles of heat-shock proteins in innate and adaptive immunity. Nat. Rev. Immunol. 2 (2002) 185-194
9. Li Z., Menoret A., and Srivastava P. Roles of heat-shock proteins in antigen presentation and cross-presentation. Curr. Opin. Immunol. 14 (2002) 45-51
10. Belli F., Testori A., Rivoltini L., Maio M., Andreola G., Sertoli M.R., Gallino G., Piris A., Cattelan A., Lazzari I., Carrabba M., Scita G., Santantonio C., Pilla L., Tragni G., Lombardo C., Arienti F., Marchiano A., Queirolo P., Bertolini F., Cova A., Lamaj E., Ascani L., Camerini R., Corsi M., Cascinelli N., Lewis J.J., Srivastava P., and Parmiani G. Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: clinical and immunologic findings. J. Clin. Oncol. 20 (2002) 4169-4180
11. Singh-Jasuja H., Scherer H.U., Hilf N., Arnold-Schild D., Rammensee H.G., Toes R.E., and Schild H. The heat shock protein gp96 induces maturation of dendritic cells and down-regulation of its receptor. Eur. J. Immunol. 30 (2000) 2211-2215
12. Singh-Jasuja H., Hilf N., Scherer H.U., Arnold-Schild D., Rammensee H.G., Toes R.E., and Schild H. The heat shock protein gp96: a receptor-targeted cross-priming carrier and activator of dendritic cells. Cell Stress Chaperones 5 (2000) 462-470
13. Basu S., Binder R.J., Suto R., Anderson K.M., and Srivastava P.K. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int. Immunol. 12 (2000) 1539-1546
14. Zheng H., Dai J., Stoilova D., and Li Z. Cell surface targeting of heat shock protein gp96 induces dendritic cell maturation and antitumor immunity. J. Immunol. 167 (2001) 6731-6735
15. Meng S.D., Gao T., Gao G.F., and Tien P. HBV-specific peptide associated with heat-shock protein gp96. Lancet 357 (2001) 528-529
16. Li H., Zhou M., Han J., Zhu X., Dong T., Gao G.F., and Tien P. Generation of murine CTL by a hepatitis B virus-specific peptide and evaluation of the adjuvant effect of heat shock protein glycoprotein 96 and its terminal fragments. J. Immunol. 174 (2005) 195-204
17. Gidalevitz T., Biswas C., Ding H., Schneidman-Duhovny D., Wolfson H.J., Stevens F., Radford S., and Argon Y. Identification of the N-terminal peptide binding site of glucose-regulated protein 94. J. Biol. Chem. 279 (2004) 16543-16552
18. Immormino R.M., Dollins D.E., Shaffer P.L., Soldano K.L., Walker M.A., and Gewirth D.T. Ligand-induced conformational shift in the N-terminal domain of GRP94, an Hsp90 chaperone. J. Biol. Chem. 279 (2004) 46162-46171
19. Rosser M.F., Trotta B.M., Marshall M.R., Berwin B., and Nicchitta C.V. Adenosine nucleotides and the regulation of GRP94-client protein interactions. Biochemistry 43 (2004) 8835-8845
20. Soldano K.L., Jivan A., Nicchitta C.V., and Gewirth D.T. Structure of the N-terminal domain of GRP94. Basis for ligand specificity and regulation. J. Biol. Chem. 278 (2003) 48330-48338
21. Ogg G.S., Jin X., Bonhoeffer S., Dunbar P.R., Nowak M.A., Monard S., Segal J.P., Cao Y., Rowland-Jones S.L., Cerundolo V., Hurley A., Markowitz M., Ho D.D., Nixon D.F., and McMichael A.J. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279 (1998) 2103-2106
22. Altman J.D., Moss P.A., Goulder P.J., Barouch D.H., McHeyzer-Williams M.G., Bell J.I., McMichael A.J., and Davis M.M. Phenotypic analysis of antigen-specific T lymphocytes. Science 274 (1996) 94-96
23. Garboczi D.N., Hung D.T., and Wiley D.C. HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc. Natl. Acad. Sci. USA 89 (1992) 3429-3433
24. Meng S.D., Song J., Rao Z., Tien P., and Gao G.F. Three-step purification of gp96 from human liver tumor tissues suitable for isolation of gp96-bound peptides. J. Immunol. Methods 264 (2002) 29-35
25. Romani N., Reider D., Heuer M., Ebner S., Kampgen E., Eibl B., Niederwieser D., and Schuler G. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J. Immunol. Methods 196 (1996) 137-151
26. Tsan M.F., and Gao B. Cytokine function of heat shock proteins. Am. J. Physiol. Cell Physiol. 286 (2004) C739-C744
27. Reed R.C., Berwin B., Baker J.P., and Nicchitta C.V. GRP94/gp96 elicits ERK activation in murine macrophages. A role for endotoxin contamination in NF-kappa B activation and nitric oxide production. J. Biol. Chem. 278 (2003) 31853-31860
28. Nicchitta C.V. Come forth CD1d: Hsp110 in the regulation of intestinal epithelial CD1d expression. J. Clin. Invest. 112 (2003) 646-648
29. Li Z., Dai J., Zheng H., Liu B., and Caudill M. An integrated view of the roles and mechanisms of heat shock protein gp96-peptide complex in eliciting immune response. Front. Biosci. 7 (2002) d731-d751
30. Nicchitta C.V. Re-evaluating the role of heat-shock protein-peptide interactions in tumour immunity. Nat. Rev. Immunol. 3 (2003) 427-432
31. Nicchitta C.V., Carrick D.M., and Baker-Lepain J.C. The messenger and the message: gp96 (GRP94)-peptide interactions in cellular immunity. Cell Stress Chaperones 9 (2004) 325-331
32. Binder R.J., Blachere N.E., and Srivastava P.K. Heat shock protein-chaperoned peptides but not free peptides introduced into the cytosol are presented efficiently by major histocompatibility complex I molecules. J. Biol. Chem. 276 (2001) 17163-17171
33. Zhu X.D., Li C.L., Lang Z.W., Gao G.F., and Tien P. Significant correlation between expression level of HSP gp96 and progression of hepatitis B virus induced diseases. World J. Gastroenterol. 10 (2004) 1141-1145